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Summary The vasculanrsation of human primary colorectal carcinomas was studied immunohistochemically.
using the endothelial cell markers CD31 and factor VIII-related antigen. Tumour sections were systematically
scanned at a magnification of x 100 to find areas of intense neovasculan'sation. Microvessel counts within
these vascular 'hotspots' were performed at magnification x 250. Regions in which tumour cords were
surrounded by a collagen IV-positive basement membrane were compared with those in which this was absent.
and with normal mucosa. CD31 appeared to be a more sensitive marker for endothelial cells than factor
VIII-related antigen (mean 185 ± 59 and 120 ± 38 microvesselsmm-2). Within individual tumour sections,
microvessel counts in vascular hotspots with highest vessel density correlated significantly with microvessel
counts in vascular hotspots with second highest vessel density (P<0.01). Microvessel counts in tumour areas
where collagen IV-positive basement membrane were absent exceeded those in areas where it was present
(factor of 1.7) and those in normal mucosa (factor of 1.6). The differences in vessel density between individual
tumours and the low variability in vessel density within individual tumours using this quantification technique
allow us to investigate the prognostic value of vessel density in areas of intense neovascularisation in human
primary colorectal carcinomas.
Keywords angiogenesis; colorectal carcinoma; quantitative pathology; CD31; immunohistochemistry
It has been shown that both for tumour growth (Folkman.
1990) and for haematogenous spread of tumour cells (Liotta
et al., 1974), the development of blood vessels towards and
into the tumour is required. This is achieved by a multistep
process referred to as tumour angiogenesis. Microvessel den-
sity of a tumour, determined on histological sections is a
quantitative measure of this process and has predictive value
for the occurrence of metastases in different tumour types
(Macchiarini et al., 1992; Wakui et al., 1992). In patients
with breast cancer, the extent of neovascularisation has been
shown to be an independent prognostic factor (Weidner et
al., 1991; Horak et al., 1992; Toi et al., 1993). In these
studies microvessels were visualised by immunostaining
endothelial cells for factor VIII-related antigen and for
CD31. A monoclonal antibody against CD31 or PECAM
(platelet-endothelial cell adhesion molecule) has been shown
to identify more vessels in tumour tissue than do antibodies
against factor VIII-related antigen (Horak et al., 1992; Toi et
al., 1993). Tumours were also observed to be heterogeneous
in their microvessel density. Angiogenesis was always scored
after counting microvessels in those tumour areas with the
most active neovascularisation.
Colorectal cancer is one of the most prevalent solid
tumours. Many clinical, biological and histological variables
have been investigated in order to understand colorectal
tumour biology and to be able to select high-risk patients for
adjuvant therapy. Nevertheless, Dukes' or TNM staging con-
tinues to be the most important prognostic factor in colorec-
tal cancer. Adjuvant chemotherapy with fluorouracil plus
levamisole reduces tumour recurrence and death rates in
patients with Dukes C carcinoma (Moertel et al., 1990).
Quantitative data on the vascularity of human colorectal
tumours are largely lacking. We initiated an immunohisto-
chemical study on neovascularisation in primary human colo-
rectal carcinomas, using monoclonal antibodies against CD31
and factor VIII-related antigen. Here, our results are dis-
cussed and compared with previously published data on
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neovasculanrsation in colorectal tumours and other tumour
types.
Materls and methods
A representative, full cross-section tumour sample. sur-
rounded by normal mucosa, was taken from 34 colorectal
cancer specimens. The largest diameter of the unfixed
tumours was assessed. Specimens were fixed in neutral for-
malin solution and processed for paraffin sections. Parallel
tumour specimens were taken and immediately frozen in
liquid nitrogen and stored at -80°C until analysis. For
routine histology, haematoxylin and eosin (HE)-stained sec-
tions were used. Five micron sections were cut, mounted on
poly-L-lysine-coated slides and dewaxed. Endogenous perox-
idase activity was quenched by exposing the slides for 30 min
to a hydrogen peroxide-in-methanol solution. Sections were
pretreated with protease type XXIV (Sigma) in TBS (Tnrs-
buffered saline) for 10 min at 37°C. Blood vessels were
visualised by staining endothelial cells for CD31 (monoclonal
antibody JC70, Dako) (Parums et al., 1990) or factor VIII-
related antigen (monoclonal antibody F8/86/3, Dako) using a
standard immunohistochemical double peroxidase/anti-per-
oxidase (PAP) technique with DAB (diaminobenzidine tetra-
hydrochloride) as chromogen. After immunostaining, a light
HE counterstain was applied before mounting in aqueous
medium. Areas of tumour without basement membrane were
differentiated from areas where it was present by HE and
collagen IV staining (monoclonal antibody, Dako).
One section per tumour was analysed. The largest diameter
of each tumour section was compared with the largest
diameter of the corresponding tumour specimen. The entire
tumour section was systematically scanned at x 100
magnification in order to find areas of most intense neovas-
cularisation. Those were identified as having the highest den-
sity of brown staining, CD31-positive cells or cell clusters.
These neovascular 'hotspots' were included into the counts
only if they were adjacent to tumour tissue.
Whenever a highly vascularised area was encountered atx 100 magnification, individual microvessels were counted
on a single x 250 field (0.4 nm2) in this area. Any brown-
staining endothelial cell or endothelial cell cluster, clearly
separated from adjacent microvessels, was regarded as a
single, countable microvessel. Neither vessel lumens nor red
blood cells were used to define a microvessel. Occasional
immunopositive macrophages and plasma cells were excluded
on morphological grounds.
After having counted vessels in the x 250 field, scanning of
the tumour section at x 100 magnification was continued
until the entire tumour section was analysed. Results on the
vascularisation of one tumour were expressed as the highest
number of microvessels identified within any single x 250
field.
The staining of vessels by two antibodies, JC70 and factor
VIII-related antigen antibody. was compared in 21 cases.
Vascular density in tumour sections stained for factor VIII-
related antigen was assessed using the same method as for
JC70-stained vessels and without the knowledge of the count-
ing results using JC70.
Areas of tumour with or without collagen IV-positive base-
ment membrane and of normal mucosa were assessed for
vessel density. Adjacent tumour sections were stained with
JC70 using the same method. Every area was systematically
scanned at x 100 magnification. Instead of counting individ-
ual microvessels at x 250 magnification, a high-power
magnification of x 400 (0.17 mm2) was applied. The counting
score of each of these different areas is represented by the
sum of the vessel counts of five highly vascularised x 400
fields.
Intra-observer variability was determined by having one
investigator analyse all tumour sections on two different days
with at least a 1 week interval. Inter-observer variability was
assessed by having a second investigator analyse a sample
representation after a short training period.
Statistical analysis was performed with the Statview 4.0
statistical software application (Abacus Concepts). The cor-
relation between different ways of microvessel counting in the
same tumour sections was analysed by Spearman rank tests.
The difference in microvessel counts encountered in different
areas within the same tumour was analysed by the Kruskal-
Wallis test. A P-value <0.01 was considered significant.
Results
Thirty-four primary colorectal carcinomas were examined.
The mean age of the patients was 65.2 years (range 37-84).
Eight tumours were located in the right colon. five in the left
colon and 21 in the rectum or rectosigmoid junction.
Tumours ranged in diameter from 1 to 9 cm (mean 4.4 cm;
standard deviation 1.7 cm). Fourteen tumours were well
differentiated, 18 moderately and two poorly. Four tumours
were classified as Dukes A. 10 as Dukes B. 18 as Dukes C
and 2 as Dukes D. Tumour sections ranged in diameter from
1 to 3.5 cm (mean 2.5 cm; standard deviation 0.5 cm). The
ratio of tumour section diameter to tumour diameter ranged
from 31.1% to 100% (mean 64.7%; standard deviation
20.2%). Considerable difference in vascular density was
observed among these tumours. Within an individual tumour
this heterogeneity in microvessel density facilitated the detec-
tion of areas of intense neovascularisation (Figures 1 and 2).
Occasionally, tumours showed a uniform and low vascular
density throughout the entire tissue section. Maximum vas-
cular counts in the tumour sections stained for CD31 varied
between 39 and 129 microvessels per x 250 field (mean 74:
standard deviation. 23 median 71) or 98 and 323 micro-
vessels mm-2 (mean 185; standard deviation 59; median 176).
Maximum vascular counts in the colorectal tumour speci-
mens stained for factor VIII-related antigen varied between
19 and 79 microvessels per x 250 field (n = 21: mean 48;
standard deviation 15; median 47) or 48 and 198 micro-
vessels mm-2 (mean 120: standard deviation 38; median 118).
JC70 appeared to be a more sensitive marker for endothelial
cells than the antibody against factor VIII-related antigen.
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Fge 1 Heterogeneity of vessel density within a tumour sec-
tion: area with high vessel density (*) and area with low vessel
density (**) in tumour tissue. Immunohistochemical staining of
endothelial cells with the anti-CD31 monoclonal antibody JC70;
haematoxylin-eosin counterstaimng.
Figre 2 Tumour cords, surrounded by stroma (arrows) contain-
ing the blood vessels. Immunohistochemical staining of endo-
thelial cells with the anti-CD31 monoclonal antibody JC70;
haematoxyhn-eosin counterstaining.
The staining of some inflammatory cells by JC70 did not
impair vascular counting. Despite the differences in endo-
thelial cell staining sensitivity and specificity between factor
VIII-related antigen staining and CD31 staining, a significant
correlation was shown by rank correlation test between both
counts (n=21; r=0.81; P<0.01) (Figure 3).
The number of vascular hotspots encountered in one
tumour section ranged from 2 to 7, partly depending on the
size of the section. The highest readings with the x 250
magnification within one tumour section were similar. In all
tumour sections, microvessel counts of vascular hotspots with
the highest vessel density correlated significantly with micro-
vessel counts of vascular hotspots with second highest vessel
density (r = 0.95; P<0.01) (Figure 4). Although these vas-
cular hotspots were mostly encountered in areas of invasive
tumour growth, they were not restricted to a limited part of
the tumour section but were frequently separated by several
millimetres of tissue with lower vascular density.
Analysis of different tumour growth areas in all tumour
sections showed a statistically significant heterogeneity of
vessel density (Kruskal-Wallis test: P<0.0001). Values of
vascular density in areas of tumour without collagen IV-Mloiassel _ua ificaioI in cal ci
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Figre 3 Microvessel counts in 21 colorectal tumour sections
stained for factor VIII-related antigen and for CD31 antigen. The
results are expressed as the highest number of microvessels
identified within any single x 250 field per tumour section
(r=0.81; P<0.01).
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Figue 4 Microvessel counts in all 34 tumour sections, stained
for CD31: microvessel counts (magnification x 250) of vascular
hotspots with highest vessel density correlate significantly with
microvessel counts of vascular hotspots with second highest vessel
density (r = 0.95; P<0.01).
positive basement membrane exceeded those in which it was
present by a factor of about 1.7 (mean 84; standard deviation
30; range 30-150; median 83 microvessels per five x 400
fields; compared with mean 49; standard deviation 13; range
32-74, median 44 microvessels per five x 400 fields) and
those of normal mucosa and submucosa by a factor of 1.6
(mean 54; standard deviation 15; range 21-84; median. 52
microvessels per five x 400 fields). Vessel density in areas of
normal mucosa and submucosa was slightly higher than
vessel density in areas of non-invasive tumour growth.
About 15 mn was required to assess one tumour. Intra-
and inter-observer variability were low. Counts performed by
one investigator correlated highly with counts performed by
the same investigator on another day (r = 0.89; P<0.000l1)
and with counts performed by a second investigator. (r=
0.79; P<0.001).
We present quantitative data on the vascularity of 34 human
colorectal carcinomas, using a monoclonal antibody against
CD31 to visualise the blood vessels. Mean microvessel count
was 185 vessels mm-' (range 98-323). Vessel density was
shown to be significantly higher in the parts of the tumours
lacking basement membrane compared with the rest (factor
of 1.7) and with normal mucosa and submucosa (factor of
1.6). Mlynek et al. (1985) used a histochemical procedure to
demonstrate alkaline phosphatase, an enzyme present in
endothelial cells of the arterial part of all capillary networks.
Ten colorectal carcinomas were thus investigated. In tumour
tissue the average number of microvessels varied between 12
and 62 vesselsmm- and vessel density of normal mucosa
exceeded that of tumour tissue by a factor of 2.3. The
coefficient of variation was much higher in tumour than in
normal tissue. Porschen et al. (1989) used a monoclonal
antibody, BW 200. recognising an endothelial cell-restricted
epitope. to stain endothelium in 13 rectal tumour cases.
Vascularity was analysed at multiple tumour sites and con-
siderable differences in vascularity between individual
tumours were observed. Vascular density appeared to be 1.6
times greater in normal tissue than in tumour tissue. The
coefficient of variation of vessel density was smaller in nor-
mal than in tumour tissue. Roncucci et al. (1992) used an
antibody against factor VIII-related antigen to identify blood
vessels in central and peripheral regions of 43 colorectal
tumours. The average number of capillaries per microscopic
field in central and peripheral tumour regions was shown to
correlate well.
Vessel density in colorectal tumour tissue in our study
appears to be much higher than in the study performed by
Mlynek et al. (1985): 185 vessels mm ' compared with 23
vesselsmnmn. This difference can be partly explained by the
vessel markers used in these studies and the different count-
ing methodology. In our study. the entire tumour-section was
carefully scanned at low-power magnification in order to find
vascular hotspots. Vessel density was assessed in one x 250
field within this highly vascular area. This excludes areas with
low vessel density from the counts. resulting in a higher mean
vessel density. In the studies by Mlynek et al. (1985) and
Porschen et al. (1989) vessel density in normal mucosa was
shown to exceed vessel density in tumour tissue by a factor
of 2.3 and 1.6 respectively. The opposite was noted in our
study: vessel density was shown to be 1.6 times higher in the
parts of the tumour lacking basement membrane compared
with normal mucosa and submucosa. Again. this probably
reflects differences in counting methodology. Both authors
have reported a heterogeneity of vascular supply in colorectal
tumour tissue, with greater coefficients of variance of vessel
density in tumour tissue as compared with normal. Within
tumour tissue, areas completely devoid of microvessels can
easily be found. whereas normal colorectal tissue shows
evenly distributed vessels.
We decided to determine microvessel density only in the
areas of the most intensive neovascularisation because this
method has recently proven to have prognostic value in
invasive breast carcinoma (Horak et al.. 1992; Weidner et al.,
1992; Toi et al., 1993). Indeed, one can speculate that the
onset of intense angiogenic activity within a tumour might be
restricted to a few areas within a tumour. The occasional
observation of a colorectal tumour with a uniformly low
vessel density could support this hypothesis. We never
encountered tumours with a uniformly high vessel density.
Our results on vessel density in colorectal carcinomas can be
compared with those observed in breast carcinomas using an
identical counting method. Weidner et al. (1992) used
antibodies to factor VIII-related antigen and obtained a
mean microvessel count of 81 mm- (range 11-226) com-
pared with our count of 120 microvessels mm-2 (range
48-198). Horak et al. (1992) counted microvessels using
CD31 and obtained a mean vascular density of 135 micro-
vessels mm-'in breast cancers, compared with our count of
185 microvessels mm-2 (range 98-323). A significantly lower
vessel density was observed in normal breast tissue, invasive
breast tumour vessel density exceeding that of normal breast
tissue by a factor of 2.1. compared with a factor of 1.6 noted
in colorectal carcinomas in our study.
CD31 was used to visualise blood vessels. It is known to
be a more sensitive marker for endothelial cells than factor
VIII-related antigen (Kuzu et al., 1992). CD31 is a platelet
t
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and endothelial cell adhesion molecule and appears to be the
only available formalin-resistant endothelial cell antigen
besides factor VIII-related antigen and CD34. In our experi-
ence, the cross-reaction of CD31 with certain inflammatory
cells, such as plasma cells or stromal cells, did not prevent
accurate microvessel identification. This cross-reactivity could
easily be discriminated from true endothelial cell reactivity on
the basis of the staining pattern and cell morphology. Toi et
al. (1993) reported a difference in cell staining sensitivity
between factor VIII-related antigen staining and CD31 stain-
ing in primary breast carcinomas. The average vessel count
for CD31 was 1.2 times higher than for factor VIII-related
antigen. A significant correlation between the two staining
methods was shown (P<O.O1). In colorectal carcinomas,
vessel counts for CD31 exceeded those for factor VIII-related
antigen by a factor of 1.6. A strong correlation between both
vessel counts was also observed in our study (P<O.O1).
Within one colorectal tumour section, vessel counts in
different vascular hotspots, separated by tumour tissue with
lower vessel density, were shown to be very similar. These
tissue sections were cut out of the tumours in a random way.
This suggests that vessel density is a stable parameter
throughout the entire colorectal tumour and might point to a
biological characteristic of a tumour. This finding is impor-
tant if quantification of angiogenesis is to become relevant as
a prognostic factor in colorectal carcinoma.
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